Alteration of tear mucin 5AC in office workers using visual display terminals: The Osaka study

Uchino Y., Uchino M., Yokoi N., Dogru M., Kawashima M., Okada N., Inaba T., Tamaki S., Komuro A., Sonomura Y., Kato H., Argüeso P., Kinoshita S., Tsubota K.

2014
JAMA Ophthalmology

View publication

Therapeutic Area

Front of the eye (FOTE)
Categories

Clinical development

Affiliations

Department of Ophthalmology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Ryogoku Eye Clinic, Tokyo, Japan; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan; Santen Pharmaceutical Co, Ltd, Osaka, Japan; Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.

Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.

Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.

View all Front of the eye (FOTE) publications